Holding Asks CMS for Reconsideration on Step Therapy

US Representative George Holding recently sent a letter to the Centers for Medicare and Medicaid Services (CMS) Administrator Seema Verma asking for reconsideration of the recent notification that Medicare Advantage plans will no longer be prohibited from using step therapy for Part B drugs.

“Given the potential impact on patient access and care, I believe CMS should pause on moving forward with this policy in 2019,” Holding wrote.

Read the letter.

 
 

Share this Post



 
 
 
 

Leave a Reply

The NCMS moderates this blog, so expect a slight delay in posting. Please include your full name and affiliation. We insist on respectful dialogue and reserve the right not to post remarks incompatible with our guidelines.

Your email address will not be published. Required fields are marked *